Table 3.
Covariates | Number of Variants | Burden Effect | Burden P Value | SKAT P Value | Sample Size |
---|---|---|---|---|---|
No covariate | 21 | −0.49 | 3.31 × 10−5 | 0.038 | 454 |
FEV1, predicted % | 21 | −0.49 | 2.92 × 10−5 | 0.032 | 454 |
FVC, predicted % | 21 | −0.47 | 6.34 × 10−5 | 0.041 | 454 |
No covariate | 21 | −0.40 | 0.012 | 0.054 | 350 |
T2D | 21 | −0.40 | 0.016 | 0.065 | 350 |
No covariate | 19 | −0.39 | 0.014 | 0.077 | 218 |
Collapsibility, % eupnea | 19 | −0.25 | 0.070 | 0.119 | 218 |
Compensation | 19 | −0.38 | 0.016 | 0.060 | 218 |
Loop gain | 19 | −0.33 | 0.020 | 0.083 | 218 |
Arousal threshold, % eupnea | 19 | −0.23 | 0.099 | 0.117 | 218 |
Definition of abbreviations: SKAT = sequence kernel association test; T2D = type 2 diabetes.